FDA Rejects Vanda Pharma's Application for Gastroparesis Drug Tradipitant
The Food and Drug Administration has turned away a proposed drug from Vanda Pharmaceuticals to treat the stomach disorder gastroparesis. Vanda on Thursday said the FDA has issued a so-called complete response letter for the drug,
2d
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...
The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
2h
Elanco Animal Health Inc. (ELAN) announced the U.S. Food and Drug Administration has approved Zenrelia, a convenient once-daily oral ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 ...
On August 6, 2024, the Food and Drug Administration (FDA) partnered with the Clinical Trials Transformation Initiative ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback